IL10 and inflammatory bowel disease: To test this hypothesis, a strain of Lactococcus lactis engineered to produce and secrete IL-10 wasconstructed and demonstrated to reduce colitis in a murine model [42].Early clinical trials in patients with inflammatory bowel disease indicate somerelief from symptoms when treated with the IL-10 overproducing strain.